Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Visx's Laser System gains supplemental PMA

This article was originally published in Clinica

Executive Summary

The STAR S4 IR, an excimer laser system developed by Visx, has gained a supplemental PMA, allowing it to be used in the US to treat myopia - shortsightedness - by removing tissue from the centre of the cornea to flatten it. It can also treat astigmatism by flattening the central cornea by different amounts and at different orientations to correct for uneven focus. It is approved to treat patients over 40 years of age with myopic astigmatism, and minimum pre-operative myopia in their non-dominant eye at least as great as their targeted eye.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049618

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel